跳至主要内容
临床试验/NCT03077763
NCT03077763Unknown1 期

The Effects of Free Haemoglobin NO-blockade on Nitrite Forearm Vessel Dilatation Under Normoxia and Hypoxia in Healthy Volunteers

University of East Anglia1 个研究点 分布在 1 个国家目标入组 41 人开始时间: 2016年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
入组人数
41
试验地点
1
主要终点
Change in FBFR during intra-brachial nitrite and haemolysed blood co-infusion in normoxia vs hypoxia.

研究概览

简要总结

The study is a pharmacodynamic random order cross-over trial investigating the physiological effects of intra-arterial infusion of nitrite following a haemolysed autologous blood transfusion.

详细描述

This is a healthy volunteer study.

Following entry into this cross-over trial, participants will be randomized to undergo experiments under either normoxic followed by hypoxic conditions, or hypoxic followed by normoxic conditions.

Subjects will donate whole blood as an autologous unit at a preselected NHSBT donation site. The unit will transported back to the NNUH blood bank after a minimum of 30 days (maximum 35 days) after donation.

Volunteers will be tested for baseline bloods. Volunteers will be randomised to normoxia or hypoxia. The will then undergo a nitrite infusion, followed by an autologous whole blood transfusion and a second nitrite infusion (which will co-infuse at the end of the transfusion). During the protocol, the participants will undergo repeated FBFR measurements using strain-gauge plethysmography.

After a minimum of 12 weeks rest period after their initial donation, participants will cross-over to the opposite oxygen condition (as per initial randomization) and the above protocol will be repeated. All interventions will be performed by fully trained and competent medical staff.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female, aged greater than or equal to 18 years
  • If between 18-20 years of age, calculate total blood volume should be more than >3.5L (http://www.blood.co.uk/giving-blood/who-can-give-blood/)
  • Body weight > 50kg weight (8 stone 12lbs)
  • Not known to have any significant past medical history and not having regular follow up (Check Donor Selection Guidelines (http://www.transfusionguidelines.org.uk/)
  • Willing to provide blood donation and receive autologous blood transfusion
  • After assessment for eligibility pass all blood donor eligibility criteria
  • Able to provide informed consent
  • Should inform overseas travel plan during study period (Check Geographical Disease Risk Index on http://www.transfusionguidelines.org.uk/dsg/gdri) e.g. unable to donate blood for 6 months if travel in a malaria endemic country. Similar guidelines for West Nile virus and T. Cruzi endemic countries.

排除标准

  • Significant medical, surgical or psychiatric disease that in the opinion of the Clinical Research Fellow would affect subject safety or significantly impact his/her ability to comply with follow-up. This would include any known clotting disorders.
  • Known allergy or intolerance to Nitrites
  • Known glucose-6-phosphate dehydrogenase (G6PD) deficiency
  • Female subjects must be of non-childbearing potential, defined as follows: postmenopausal females who have had at least 12 months of spontaneous amenorrhea or 6 months of spontaneous amenorrhoea with serum FSH>40mIU/ml or females who have had a hysterectomy, bilateral salpingectomy or bilateral oophorectomy at least 6 weeks prior to enrolment
  • Receipt of an investigational drug or biological agent within the 4 weeks prior to study entry or 5 times the drug half-life, whichever is the longer
  • Predisposed to acute on chronic limb ischemia evident from a history of claudication or known peripheral arterial disease.
  • No past history of significant adverse events post blood donation

研究组 & 干预措施

Normoxia and Nitrite (3umol/min-1)

Active Comparator

Sodium nitrite stock solution: 100umol/10ml, prepared to concentration according to oxygen sequence. Normoxia (3umol/min-1).

干预措施: Sodium Nitrite (Drug)

Hypoxia and Nitrite (1umol/min-1)

Active Comparator

This will be repeated as per the normoxia cohort, but at a reduced dose of sodium nitrite (1umol/min-1 for 30 minutes) and the volunteers will be asked to breathe 12% oxygen/88% nitrogen for 1-5 minutes before Plethysmography is performed (to get the volunteer to an oxygen saturation of 83-88% peripherally).

干预措施: Sodium Nitrite (Drug)

结局指标

主要结局

Change in FBFR during intra-brachial nitrite and haemolysed blood co-infusion in normoxia vs hypoxia.

时间窗: Up to 18 months

次要结局

  • Change in FBFR during nitrite infusion in normoxia vs nitrite infusion in hypoxia(Up to 18 months)
  • Change in FBFR during haemolysed blood infusion vs baseline(Up to 18 months)
  • Blood analysis (cell free haemoglobin, nitrate, nitrite and nitroso species levels)(Up to 18 months)
  • Change in FBFR during nitrite infusion in normoxia vs baseline(Up to 18 months)
  • Change in FBFR during nitrite infusion in hypoxia vs baseline(Up to 18 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验